(Q42547414)

2 November 2017

Comparative in vivo and in vitro studies with the potent GABAB receptor antagonist, CGP 56999A. (English)

1 reference

2 November 2017

Badran S

1

1 reference

2 November 2017

Schmutz M

series ordinal

2

1 reference

2 November 2017

Olpe HR

series ordinal

3

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 August 1997

1 reference

European Journal of Pharmacology

2 November 2017

1 reference

2 November 2017

333

1 reference

2 November 2017

2-3

1 reference

2 November 2017

135-142

1 reference

GABAB receptor pharmacology

2 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901111-4

Intrinsic firing patterns of diverse neocortical neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901111-4

GABAB receptors in various in vitro and in vivo models of epilepsy: A study with the GABAB receptor blocker CGP 35348

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901111-4

The actions of orally active GABAB receptor antagonists on GABAergic transmission in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901111-4

GABA and glutamate release affected by GABAB receptor antagonists with similar potency: no evidence for pharmacologically different presynaptic receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901111-4

10.1016/S0014-2999(97)01111-4

7 January 2021

Identifiers

DOI

1 reference

2 November 2017

1 reference